James Paxton

Jan 9, 2025 | digitalcommons.library.tmc.edu | Moisés Huamán |JAY RAVAL |James Paxton |Giselle Mosnaim

BACKGROUND: COVID-19 convalescent plasma (CCP) is an important therapeutic option for outpatients at high risk of hospitalization from SARS-CoV-2 infection. We assessed the safety of outpatient CCP transfusions administered during clinical trials. STUDY DESIGN AND METHODS: We analyzed data pertaining to transfusion-related reactions from two randomized controlled trials in the U.S. that evaluated the efficacy of CCP versus control plasma in various ambulatory settings.

Jul 23, 2024 | worldbaseball.com | Dave Roberts |James Paxton |Tyler Glasnow

About 3 minutes reading time. LOS ANGELES (AP) — The Los Angeles Dodgers made a surprising change to their evolving rotation Monday. James Paxton was designated for assignment to make room for River Ryan on the 40-man roster. Ryan made his major league debut Monday night against the San Francisco Giants, becoming the 14th pitcher to start for the Dodgers this season. Paxton was tied with Gavin Stone and Tyler Glasnow for most starts on the team with 18.

Jul 22, 2024 | septimaentrada.com | James Paxton

A pesar de la gran ausencia de pitchers abridores con las que han tenido que lidiar durante las últimas semanas, la gerencia de los Dodgers colocó en asignación al zurdo James Paxton este lunes aún cuando se acreditó la victoria en el juego de un día antes frente a los Red Sox.

Jul 22, 2024 | fansided.com | James Paxton

Los Dodgers de Los Angeles colocaron este lunes a James Paxton en asignación de forma sorpresiva, ya que aunque ha batallado con su control durante toda la temporada (es líder en boletos de la Liga Nacional con 48), no es menos cierto que el cuerpo de lanzadores del manager Dave Roberts ha sufrido varias bajas importantes por lesiones.

Feb 5, 2024 | digitalrepository.unm.edu | Moisés Huamán |JAY RAVAL |James Paxton |Giselle Mosnaim

BACKGROUND: COVID-19 convalescent plasma (CCP) is an important therapeutic option for outpatients at high risk of hospitalization from SARS-CoV-2 infection. We assessed the safety of outpatient CCP transfusions administered during clinical trials. STUDY DESIGN AND METHODS: We analyzed data pertaining to transfusion-related reactions from two randomized controlled trials in the U.S. that evaluated the efficacy of CCP versus control plasma in various ambulatory settings.